Gainers
- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy.
- Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) shares surged 44.3% to $4.7893 after Alliance Global Partners initiated coverage on the stock with a Buy rating and a $20 price target.
- IMARA Inc. (NASDAQ:IMRA) rose 37% to $1.57 after the company announced it entered into an asset purchase agreement with Cardurion Pharmaceuticals to sell tovinontrine and other assets of its PDE9 program for $34.75 million upfront.
- Sidus Space, Inc. (NASDAQ:SIDU) gained 26.7% to $3.3701 after the company announced that it has signed a launch agreement with SpaceX for five launches, beginning in early 2023.
- Cryo-Cell International, Inc. (NYSE:CCEL) jumped 17.7% to $7.86.
- bioAffinity Technologies, Inc. (NASDAQ:BIAF) rose 19.7% to $6.45 after dropping around 24% on Tuesday. The company, last week, priced its IPO at $6.125 per unit.
- Azure Power Global Limited (NYSE:AZRE) shares gained 17.3% to $4.21. Azure Power Global recently announced the resignation of Harsh Shah as CEO.
- Pingtan Marine Enterprise Ltd. (NASDAQ:PME) jumped 17.3% to $0.8565.
- Glaukos Corporation (NYSE:GKOS) gained 17.3% to $56.40 after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved its pre-specified primary efficacy endpoints through 3 months in both Phase 3 trials and demonstrated excellent tolerability and a favorable safety profile through 12 months.
- Aquestive Therapeutics, Inc. (NASDAQ:AQST) rose 16.8% to $1.4599. Oppenheimer initiated coverage on Aquestive Therapeutics with an Outperform rating and announced a price target of $8.5.
- Spero Therapeutics, Inc. (NASDAQ:SPRO) shares rose 16.4% to $1.3150. Spero Therapeutics shares jumped over 55% on Tuesday after the company received minutes from a Type A meeting with the FDA discussing steps required to resubmit the marketing application for tebipenem HBr.
- Biophytis S.A. (NASDAQ:BPTS) shares gained 16% to $1.0899 after the company released topline results from its phase 2-3 COVA study evaluating Sarconeos (BIO101) in treating COVID-19-related respiratory failure.
- SelectQuote, Inc. (NYSE:SLQT) rose 15.4% to $1.2808.
- Seres Therapeutics, Inc. (NASDAQ:MCRB) gained 14.2% to $6.16. Seres Therapeutics announced completion of rolling BLA submission to the FDA for investigational microbiome therapeutic SER-109 for recurrent C. Difficile infection.
- Academy Sports and Outdoors, Inc. (NASDAQ:ASO) jumped 12% to $46.98. Academy Sports And Outdoors reported a second-quarter FY22 sales decline of 5.8% year-on-year to $1.69 billion.
- Nutex Health, Inc. (NASDAQ:NUTX) jumped 11.5% to $2.90.
- Unico American Corporation (NASDAQ:UNAM) gained 10.6% to $1.8580.
- Coupa Software Incorporated (NASDAQ:COUP) rose 10.5% to $61.65 as the company posted better-than-expected results for its second quarter and issued strong forecast for FY23. The company also announced a $100 million buyback program.
- Tempur Sealy International, Inc. (NYSE:TPX) jumped 8.2% to $26.39.
- InMed Pharmaceuticals Inc. (NASDAQ:INM) gained 7.6% to $9.47.
- Baudax Bio, Inc. (NASDAQ:BXRX) rose 7.6% to $0.3243 after declining over 7% on Tuesday. Baudax Bio recently announced the pricing of a $6.2 million public offering.
